Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001023024-06-000034
Filing Date
2006-09-06
Accepted
2006-09-05 18:21:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 BIOSANTE PHARMA, 2006 PIPE 424(B)(3) biosante06424b3.htm 424B3 375967
  Complete submission text file 0001023024-06-000034.txt   377463
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-136852 | Film No.: 061075058
SIC: 2836 Biological Products, (No Diagnostic Substances)